Vitamin C linked to fewer deaths in blood disorder trial

Saturday, October 3, 2026

Want headlines delivered to your inbox?
Subscribe to our free daily newsletter.

Search Headlines:

Match Type:BroadStrict



Vitamin C may do more than support the immune system. In a phase 2 trial of people with precancerous or low risk blood cancers, daily vitamin C did not slow abnormal cell growth, but it was linked to favorable changes in inflammation and fewer serious complications. An exploratory follow up also found fewer deaths among participants taking vitamin C than among those receiving placebo. (via Science Daily)

Read the Full Story
This article will expire in 25 days.

In the News...

View All Recent News

Note: News headlines appearing on this site do not reflect the opinion of RxChat.com or its staff.